Nanomnia
Provides fully-organic, biodegradable, and microplastic-free nano, micro, and macro encapsulation services for active ingredients in agrochemicals, cosmetics, nutraceuticals, pharmaceuticals, and smart materials.
- CEO / Founder
- Marta Bonaconsa
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $300K
- Latest Round
- Crowdfunding
- Key Investors
- 20Fund
Technology & Products
Key Products
Encapsulation of essential oils; Organic encapsulation of microorganisms; Luminescent nanomaterial additives for solar cells; Analytical chemistry services
Technological Advantage
Proprietary organic encapsulation process that enhances active ingredient stability and efficacy, protected by pending patents (e.g., for microbial biostimulants).
Differentiation
Value Proposition
Offers R&D services for custom encapsulation formulations, enabling clients to improve product efficacy, reduce volatility, prolong release, and ensure regulatory compliance with sustainable, biocompatible solutions.
How They Differentiate
Focus on fully-organic, biodegradable, and microplastic-free encapsulation vs. conventional synthetic methods; offers end-to-end R&D services from prototyping to regulatory compliance.
Market & Competition
Target Customers
Agrochemical, cosmetics, nutraceutical, pharmaceutical, and smart material companies
Industry Verticals
Agrochemical; Cosmetics; Nutraceutical; Pharmaceutical; Advanced Materials
Growth & Milestones
Growth Metrics
Raised approximately €800k from public grants, institutional investors, and industry professionals as of latest reports. Recognized in Forbes Italy's 100 successful women list (2024) with Marta Bonaconsa as molecular biologist. Team includes founders Marta Bonaconsa, Michele Bovi, Pietro Vaccari, plus Stefania Boi, Claudia Mezzalira, Matteo Caputo, Cristina Panara, Andrea Colusso, Elisa Bancalà. Industrial partner: Paolo Dussin (CEO of DMD Srl and Versan&Dafne Srl).
Major Milestones
Founded in 2017; Listed in VoxelMatters AM directory; Collaborations with institutions like Agrea and Crea